Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway

1 S. Toldo and A. Abbate, The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases, Nat. Rev. Cardiol. 21 (2024) 219–237; https://doi.org/10.1038/s41569-023-00946-3 Search in Google Scholar

2 S. Toldo, E. Mezzaroma, L. F. Buckley, N. Potere, M. Di Nisio, G. Biondi-Zoccai, B. W. Van Tassell and A. Abbate, Targeting the NLRP3 inflammasome in cardiovascular diseases; Pharmacol. Ther. 236 (2022) Article ID 108053; https://doi.org/10.1016/j.pharmthera.2021.108053 Search in Google Scholar

3 C. Pellegrini, A. Martelli, L. Antonioli, M. Fornai, C. Blandizzi and V. Calderone, NLRP3 inflamma-some in cardiovascular diseases: Pathophysiological and pharmacological implications, Med. Res. Rev. 41(4) (2021) 1890–1926; https://doi.org/10.1002/med.21781 Search in Google Scholar

4 H. Y. Fang, X. N. Zhao, M. Zhang, Y. Y. Ma, J. L. Huang and P. Zhou, Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome, Inflammopharmacol. 31 (2023) 1715–1729; https://doi.org/10.1007/s10787-023-01249-2 Search in Google Scholar

5 J. P. Li, S. Qiu, G. J. Tai, Y. M. Liu, W. Wei, M. M. Fu, P. Q. Fang, J. N. Otieno, T. Battulga, X. X. Li and M. Xu, NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/Akt/mTOR pathway in diabetic myocardial infarction, Cardiovasc. Diabetol. 24 (2025) Article ID 6 (23 pages); https://doi.org/10.1186/s12933-024-02541-3 Search in Google Scholar

6 W. Zhou, C. Chen, Z. Chen, L. Liu, J. Jiang, Z. Wu, M. Zhao and Y. Chen, NLRP3: A novel mediator in cardiovascular disease, J. Immunol. Res. 2018 (2018) Article ID 5702103 (8 pages); https://doi.org/10.1155/2018/5702103 Search in Google Scholar

7 J. Fu and H. Wu, Structural mechanisms of NLRP3 inflammasome assembly and activation, Annu. Rev. Immunol. 41 (2023) 301–316; https://doi.org/10.1146/annurev-immunol-081022-021207 Search in Google Scholar

8 Y. Xie, G. Sun, Y. Tao, W. Zhang, S. Yang, L. Zhang, Y. Lu and G. Du, Current advances on the therapeutic potential of scutellarin: An updated review, Nat. Prod. Bioprospect. 14 (2024) Article ID 20 (15 pages); https://doi.org/10.1007/s13659-024-00441-3 Search in Google Scholar

9 Y. Zhou, C. Gu, Y. Zhu, Y. Zhu, Y. Chen, L. Shi, Y. Yang, X. Lu and H. Pang, Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: A review, Front Pharmacol. 15 (2024) Article ID 1463140 (15 pages); https://doi.org/10.3389/fphar.2024.1463140 Search in Google Scholar

10 X. Zhang, T. Yin, Y. Wang, J. Du, J. Dou and X. Zhang, Effects of scutellarin on the mechanism of cardiovascular diseases: A review, Front. Pharmacol. 14 (2024) Article ID 1329969 (19 pages); https://doi.org/10.3389/fphar.2023.1329969 Search in Google Scholar

11 L. J. Xu, R. C. Chen, X. Y. Ma, Y. Zhu, G. B. Sun and X. B. Sun, Scutellarin protects against myocar-dial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation, Phytomedicine 68 (2020) Article ID Article ID 153169 (11 pages); https://doi.org/10.1016/j.phymed.2020.153169 Search in Google Scholar

12 H. Sharif, L. Wang, W. L. Wang, V. G. Magupalli, L. Andreeva, Q. Qiao, A. V. Hauenstein, Z. Wu, G. Núñez, Y. Mao and H. Wu, Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome, Nature 570 (2019) 338–343; https://doi.org/10.1038/s41586-019-1295-z Search in Google Scholar

13 B. T. Fahr, T. O’Brien, P. Pham, N. D. Waal, S. Baskaran, B. C. Raimundo, J. W. Lam, M. M. Sopko, H. E. Purkey and M. J. Romanowski, Tethering identifies fragment that yields potent inhibitors of human caspase-1, Bioorg. Med. Chem. Lett. 16(3) (2006) 559–562; https://doi.org/10.1016/j.bmcl.2005.10.048 Search in Google Scholar

14 S. Kuang, J. Zheng, H. Yang, S. Li, S. Duan, Y. Shen, C. Ji, J. Gan, X. W. Xu and J. Li, Structure insight of GSDMD reveals the basis of GSDMD autoinhibition in cell pyroptosis, Proc. Natl. Acad. Sci. USA 114(40) (2017) 10642–10647. https://doi.org/10.1073/pnas.1708194114 Search in Google Scholar

15 Y. Liu, X. Yang, J. Gan, S. Chen, Z. X. Xiao and Y. Cao, CB-Dock2: Improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting, Nucleic Acids Res. 50(W1) (2022) W159-W164; https://doi.org/10.1093/nar/gkac394 Search in Google Scholar

16 X. N. Zhao, H. M. Ding, Y. Y. Ma, L. Wang and P. Zhou, Ling-Gui-Zhu-Gan decoction inhibits cardiomyocyte pyroptosis via the NLRP3/Caspase-1 signaling pathway, Tissue Cell. 91 (2024) Article ID 102588; https://doi.org/10.1016/j.tice.2024.102588 Search in Google Scholar

17 X. Chen, Y. Li, J. Li, T. Liu, Q. Jiang, Y. Hong, Q. Wang, C. Li, D. Guo and Y. Wang, Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats, J. Ethnopharmacol. 285 (2025) Article ID 114841; https://doi.org/10.1016/j.jep.2021.114841 Search in Google Scholar

18 Y. Qiu, Y. Huang, M. Chen, Y. Yang, X. Li and W. Zhang, Mitochondrial DNA in NLRP3 inflamma-some activation, Int. Immunopharmacol. 108 (2022) Article ID 108719; https://doi.org/10.1016/j.intimp.2022.108719 Search in Google Scholar

19 N. Kelley, D. Jeltema, Y. Duan and Y. He, The NLRP3 inflammasome: An overview of mechanisms of activation and regulation, Int. J. Mol. Sci. 20(13) (2019) Article ID 3328 (24 pages); https://doi.org/10.3390/ijms20133328 Search in Google Scholar

20 Y. Huang, W. Xu and R. Zhou, NLRP3 inflammasome activation and cell death, Cell Mol. Immunol. 18 (2021) 2114–2127; https://doi.org/10.1038/s41423-021-00740-6 Search in Google Scholar

21 A. Rauf, M. Shah, D. M. Yellon and S. M. Davidson, Role of caspase 1 in ischemia/reperfusion injury of the myocardium, J. Cardiovasc. Pharmacol. 74(3) (2019) 194–200; https://doi.org/10.1097/FJC.0000000000000694 Search in Google Scholar

22 B. Zhang, G. Liu, B. Huang, H. Liu, H. Jiang, Z. Hu and J. Chen, KDM3A attenuates myocardial ischemic and reperfusion injury by ameliorating cardiac microvascular endothelial cell pyroptosis, Oxid. Med. Cell Longev. 2022 (2022) Article ID 4622520 (19 pages); https://doi.org/10.1155/2022/4622520 Search in Google Scholar

23 S. Toldo and A. Abbate, The NLRP3 inflammasome in acute myocardial infarction, Nat. Rev. Cardiol. 15 (2018) 203–214; https://doi.org/10.1038/nrcardio.2017.161 Search in Google Scholar

24 Y. S. Tang, Y. H. Zhao, Y. Zhong, X. Z. Li, J. X. Pu, Y. C. Luo and Q. L. Zhou, Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway, Inflamm. Res. 68 (2019) 727–738. https://doi.org/10.1007/s00011-019-01256-6 Search in Google Scholar

25 E. L. Johnston, B. Heras, T. A. Kufer and M. Kaparakis-Liaskos, Detection of bacterial membrane vesicles by NOD-like receptors, Int. J. Mol. Sci. 22(3) (2021) Article ID 1005 (14 pages); https://doi.org/10.3390/ijms22031005 Search in Google Scholar

26 H. Kong, H. Zhao, T. Chen, Y. Song and Y. Cui, Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy, Cell Death Dis. 13 (2022) Article ID 336 (13 pages); https://doi.org/10.1038/s41419-022-04786-w Search in Google Scholar

27 S. Nie, S. Zhang, R. Wu, Y. Zhao, Y. Wang, X. Wang, M. Zhu and P. Huang, Scutellarin: Pharmacological effects and therapeutic mechanisms in chronic diseases, Front Pharmacol. 15 (2024) Article ID 1470879 (23 pages); https://doi.org/10.3389/fphar.2024.1470879 Search in Google Scholar

28 J. K. Li, Z. P. Song and X. Z. Hou, Scutellarin ameliorates ischemia/reperfusion injury-induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS-STING pathway, Exp. Ther. Med. 25(4) (2023) Article ID 155 (9 pages); https://doi.org/10.3892/etm.2023.11854 Search in Google Scholar

29 X. Fan, Y. Wang, X. Li, T. Zhong, C. Cheng and Y. Zhang, Scutellarin alleviates liver injury in type 2 diabetic mellitus by suppressing hepatocyte apoptosis in vitro and in vivo, Chin. Herb Med. 15(4) (2023) 542–548; https://doi.org/10.1016/j.chmed.2023.03.007 Search in Google Scholar

30 L. Peng, L. Wen, Q. F. Shi, F. Gao, B. Huang, J. Meng, C. P. Hu and C. M. Wang, Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation, Cell Death Dis. 11 (2020) Article ID 978 (16 pages); https://doi.org/10.1038/s41419-020-03178-2 Search in Google Scholar

31 W. C. Gao, T. H. Yang, B. B. Wang, Q. Liu, Q. Li, Z. H. Zhou, C. B. Zheng and P. Chen, Scutellarin inhibits oleic acid induced vascular smooth muscle foam cell formation via activating autophagy and inhibiting NLRP3 inflammasome activation, Clin. Exp. Pharmacol. Physiol. 51(4) (2024) e13845; https://doi.org/10.1111/1440-1681.13845 Search in Google Scholar

32 Z. Wang, P. Zhang, Y. Zhao, F. Yu, S. Wang, K. Liu, X. Cheng, J. Shi, Q. He, Y. Xia and L. Cheng, Scutellarin protects against mitochondrial reactive oxygen species-dependent NLRP3 inflamma-some activation to attenuate intervertebral disc degeneration, Front. Bioeng. Biotechnol. 10 (2022) Article ID 883118 (17 pages); https://doi.org/10.3389/fbioe.2022.883118 Search in Google Scholar

33 H. T. Bian, G. H. Wang, J. J. Huang, L. Liang, L. Xiao, and H. L. Wang, Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats, Int. Immunopharmacol. 88 (2020) Article ID106943 (7 pages); https://doi.org/10.1016/j.intimp.2020.106943 Search in Google Scholar